Nacl Industries Ltd · NSE:NACLIND

Nacl Industries — Q3 FY2022 Earnings Presentation

45 slides from Nacl Industries's earnings presentation, Jan 29, 2022

  1. Slide 1: Exchange filing cover letter: Investor Presentation

    A NACL Industries Limited Nf\GARJUNA_ NACL Ref: NACL/SE/2021-22 January 29, 2022 1) BSE Limited 2) National Stock ?xchange of India Ltd Phiroze Jeejeebhoy Towers Exchange Plaza, 5thFloor Dalal Street, Plot No.Cf 1 G Block, Fort, Mumbai, Bandra -Kurla Complex, Bandra (E) Mumbai- 400001 Mumbai-400051.

  2. Slide 2: NACL Industries Limited Investor Presentation Q3 FY2022

    NACL INDUSTRIES LIMITED Investor Presentation Q3 FY2022

  3. Slide 3: Forward Looking Statement

    FORWARD LOOKING STATEMENT This presentation contains forward-looking statements, including, but not limited to, the statements and expectations contained in this presentation. Statements herein, other than statements of historical fact, regarding future events or prospects, are forward-looking state

  4. Slide 4: Table Of Content

    CORPORATE IDENTITY OPERATIONAL HIGHLIGHTS RESULTS SUMMARY Table Of Content PERFORMANCE TRACK RECORD ANNEXURE SHAREHOLDERS INFORMATION

  5. Slide 5: Corporate Identity

    ems CORPORATE IDENTITY

  6. Slide 6: About NACL

    ABOUT NACL NACL is an established agrochemical Company in India, founded in 1993. The Company started as an Active Ingredient manufacturer and has built a sizable business in Domestic Retail, B2B and Exports, with many of the customers being large MNCs with long-standing relationships. Values • Conc

  7. Slide 7: Quick Facts

    QUICK FACTS 5 57 30 25+ Million Farmers Branded Geographical Years of ( Customers ) Products Presence Experience 12,500 3 1200+ Retailers Manufacturing Units Employee Strength 6

  8. Slide 8: Geographical Reach

    GEOGRAPHICAL REACH 30 Countries USA 12,500 Retailers Uzbekistan Iran 35 Revenue from International (%) Lebanon Nepal Egypt Taiwan 03 Manufacturing Plants Thailand Sudan Jordan India Costa Rica Yemen Columbia Uganda Ethiopia Ecuador Tanzania Sri Lanka Brazil Zambia Paraguay Myanmar Argentina Australi

  9. Slide 9: Product Portfolio – Technicals

    PRODUCT PORTFOLIO Technicals • Myclobutanil Insecticides Herbicides • Propiconazole • Tricyclazole • Thifluzamide • Difenoconazole • Profenofos • Pretilachlor • Lambda-Cyhalothrin • Bispyribac Sodium • Imidacloprid • Metribuzin • Bifenthrin • Clodinafop-Propargyl • Thiamethoxam • Quizalofop ethyl •

  10. Slide 10: Product Portfolio – Insecticides, Herbicides, Fungicides

    PRODUCT PORTFOLIO Insecticides Herbicides Insecticides • Atonik • Cairo • Pest Lock • Combi plus • Zeb • Eraze • Point • Gallant EG • Cannon • Profex • Font • Zen • Eraze N • Rhino • Gallant Gold • Dxtar • Profex Super • Index • Rhizostar • Eraze Plus • Senior • Dxtar FS • Pymet • Kazan • Eraze Stro

  11. Slide 11: Product Launch During Q3FY22

    PRODUCT LAUNCH DURING Q3FY22 Nagastra Strong Hurricane Plus Nagastra strong (Pendimethalin 38.7 % CS) is herbicide which is an advance Hurricane Plus is combination of two active ingredients Novaluran 5.25% + version of Nagastra. It belongs to the Dinitroaniline group. It inhibits cell Emamectin Ben

  12. Slide 12: Operational Highlights

    ees OPERATIONAL HIGHLIGHTS

  13. Slide 13: Operational Highlights for Q3FY22

    OPERATIONAL HIGHLIGHTS FOR Q3FY22 For the quarter ending December'21, Revenue from operations stood at ₹ 40,480 lakhs, registering a growth of 51% YoY and recorded Profit after tax of ₹ 1 1,547 lakhs registering a growth of 70% YoY For the quarter ending December'21, Exports business has almost doub

  14. Slide 14: Results Summary

    eee RESULTS SUMMARY

  15. Slide 15: Result Summary – Q3FY22

    RESULT SUMMARY – Q3FY22 (In ₹ lakhs) Revenue EBITDA PAT 51% 23% 70% 39,976 3,565 1,547 26,475 2,888 910 Q3FY21 Q3FY22 Q3FY21 Q3FY22 Q3FY21 Q3FY22 Revenue Breakup (₹ in lakhs) Insecticides Herbicides Fungicides Plant Growth Regulators 53% (0.1%) 82% 17% Q3FY22 14,568 5,717 17,438 1,230 Q3FY21 9,492 5

  16. Slide 16: Revenue Split – Q3FY22

    REVENUE SPLIT – Q3FY22 Q3FY22 Q3FY21 Product Category-wise (%) Product Category-wise (%) Formulation Technical Formulation Technical 4% 2% 5% 3% 23% 29% 22% 28% 48% 49% 54% 59% 10% 20% 20% 24% Insecticides Herbicides Fungicides Plant Growth Regulators, Nematicides & others Insecticides Herbicides Fu

  17. Slide 17: Result Summary – 9MFY22

    RESULT SUMMARY – 9MFY22 (In ₹ lakhs) Revenue EBITDA PAT 36% 23% 66% 5,502 1,16,729 11,448 86,094 9,285 3,315 9MFY21 9MFY22 9MFY21 9MFY22 9MFY21 9MFY22 Revenue Breakup (₹ in lakhs) Insecticides Herbicides Fungicides Plant Growth Regulators 33% 13% 53% 33% 9MFY22 48,682 19,461 42,785 3,064 9MFY21 36,5

  18. Slide 18: Revenue Split – 9MFY22

    REVENUE SPLIT – 9MFY22 9MFY22 9MFY21 Product Category-wise (%) Product Category-wise (%) Formulation Technical Formulation Technical 4% 2% 4% 1% 18% 23% 21% 29% 56% 54% 52% 60% 18% 19% 24% 15% Insecticides Herbicides Fungicides Plant Growth Regulators, Nematicides & others Insecticides Herbicides Fu

  19. Slide 19: Profit and Loss – Q3FY22 (Standalone)

    PROFIT AND LOSS – Q3FY22 (Standalone) Particulars Q3FY22 Q3FY21 Q2FY22 Y-o-Y (%) 9MFY22 9MFY21 Y-o-Y (%) Revenue from operations 39,976 26,475 44,285 51% 1,16,729 86,094 36% Other income 504 307 547 64% 1366 887 54% Total Income 40,480 26,782 44,832 51% 1,18,095 86,981 36% Expenses: (a) Cost of mate

  20. Slide 20: Profit and Loss – Q3FY22 (Consolidated)

    PROFIT AND LOSS – Q3FY22 (Consolidated) Particulars Q3FY22 Q3FY21 Q2FY22 Y-o-Y (%) 9MFY22 9MFY21 Y-o-Y (%) Revenue from operations 39,976 26,475 44,285 51% 116,729 86,094 36% Other income 431 301 483 43% 1181 882 34% Total Income 40,407 26,776 44,768 51% 117,910 86,976 36% Expenses: (a) Cost of mate

  21. Slide 21: Performance Track Record

    ee PERFORMANCE TRACK RECORD

  22. Slide 22: Historic Quarterly Trend (1/2)

    HISTORIC QUARTERLY TREND (1/2) (₹ in lakhs) Revenue from Operations EBITDA and EBITDA Margin 3,000 50,000 44,285 45,000 2,500 10.55% 39,976 40,000 34,417 2,000 12.28% 35,000 33,043 32,468 10.45% 30,172 8.81% 30,000 27,663 27,611 1,500 9.62% 26,475 25,202 10.78% 25,000 23,868 21,820 1,000 19,099 19,5

  23. Slide 23: Historic Quarterly Trend (2/2)

    HISTORIC QUARTERLY TREND (2/2) (₹ in lakhs) PBT and PBT Margin PBT and PBT Margin 3,000 3,000 7.60% 5.63% 2,500 2,500 2,000 8.42% 2,000 5.39% 6.65% 5.09% 5.27% 3.82% 1,500 5.81% 1,500 4.37% 3.40% 5.35% 1,000 2.11% 1,000 3.35% 1.80% 2.10% 1.89% 0.72% 2.53% 3.15% 2.89% 500 0.49% 500 0.92% 1.76% 1.28%

  24. Slide 24: Financial Performance (1/2)

    FINANCIAL PERFORMANCE (1/2) (₹ in lakhs) Revenue from Operations EBITDA and EBITDA Margin CAGR 10.17% CAGR 12.48% 1,19,137 14,0 00 10.61% 12. 00% 1,01,489 8.37% 12,0 00 10. 00% 7.66% 7.44% 84,606 86,549 10,0 00 12,806 8.0 0% 73,411 8,00 0 4.42% 6.0 0% 6,00 0 7,607 4,00 0 7,113 6,777 4.0 0% 2,00 0 3,

  25. Slide 25: Financial Performance (2/2)

    FINANCIAL PERFORMANCE (2/2) (₹ in lakhs) Working Capital Days Net Worth 154 41,148 134 131 35,053 27,865 22,588 23,500 79 82 FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21 ROCE and ROE Debt to Equity (x) 20.68% 0.21 0.20 17.57% 15.84% 13.57% 0.16 12.22% 14.04% 6.27% 0.10 4.56% 4.50% 0.09 -3.01% F

  26. Slide 26: Credit Rating

    CREDIT RATING Long Term Bank Facilities Short Term Bank Facilities ₹ 400.38 ₹ 115.00 Crores Crores CARE A; Stable CARE A1 (A One) (Single A; Outlook: Stable) Reaffirmed Reaffirmed 25

  27. Slide 27: Annexure

    ANNEXURE

  28. Slide 28: Timeline (1/2)

    TIMELINE (1/2) Project Work on Started exporting SAP 2nd Technical the products (Enterprise Resource Manufacturing Block manufactured from Planning) was The 5th Technical for manufacturing the Technical successfully Manufacturing block Acephate was initiated Manufacturing Plant implemented was estab

  29. Slide 29: Timeline (2/2)

    TIMELINE (2/2) Co-marketing Bagged “India's Best partnership with Company of the Year leading Japanese Award – 2017”, by Registered highest State-of-the-Art chemical companies International Brand ever turnover of Research & for Herbicide - Sirius Consulting Corporation, Rs.1000 crores Development &

  30. Slide 30: Board of Directors

    BOARD OF DIRECTORS Mrs. K Lakshmi Raju Mr. M Pavan Kumar Mr. Sudhakar Kudva Mr. N Vijayaraghavan Mr. Raghavender Mateti Chairperson & Managing Director & Independent Director Non-Executive Director Independent Director Non-Executive Director CEO Mr. Ramkrishna Mudholkar Mr. N Sambasiva Rao Ms. Veni

  31. Slide 31: Key Management Team

    KEY MANAGEMENT TEAM Mr. M Pavan Kumar Mr. R.K.S Prasad Mr. G. Jagannadha Rao Mr. C. Varada Rajulu Mr. Harish Chandra Bijlwan Managing Director & CEO Executive VP – Finance & Executive VP – Exports Sales Senior VP –Operations Senior VP – Operations & CFO & Marketing (Srikakulam and Ethakota Plants) T

  32. Slide 32: NACL's Business Model

    NACL’S BUSINESS MODEL Technical manufacturing plant 50+ Branded Products, 47 NACL stock points with a production capacity of and 12,500 retail outlets across India under the 10,000 metric tons per annum Company’s direct to retail approach A state-of-the-art Formulation unit with packaging Knowledge

  33. Slide 33: Business Strategy

    BUSINESS STRATEGY Strengthening and enhancing Substantial capacity enhancement global collaborations strategy in Agrochemical, Specialty Chemicals & Advanced Intermediaries Continue to invest in Product Registrations, Process know – how, Brand building Tap new geographies and spread distribution net

  34. Slide 34: NACL – A Unique Investment Case

    NACL – A UNIQUE INVESTMENT CASE 01 02 03 04 RESEARCH & GOVERNANCE DEVELOPMENT & LEADERSHIP CONSISTENT DISTRIBUTION GROWTH NETWORK Capable R&D team with state-of- Accomplished Board Members the-art, GLP accredited facility, to and seasoned professional Sustained improvement Extensive market reach dev

  35. Slide 35: Certificates

    CERTIFICATES RC certificate GLP certificate ISO ACCREDITATIONS NABL ACCREDITATIONS ISO 45001:2018 ISO 14001:2015 ISO 9001:2015 R&D Facility Ethakota Unit Srikakulam Unit DSIR 34

  36. Slide 36: Awards and Accolades

    AWARDS AND ACCOLADES Best Company of Greentech Award Suraksha Puraskar Certificate of Best Management Water Industry Champion the Year 2017 Appreciation Award Management Award 2021 NACL has bagged the NACL’s Srikakulam Award NACL has been “Greentech Unit has bagged the NACL’s Ethakota NACL’s manufac

  37. Slide 37: Key External Drivers of the Business

    KEY EXTERNAL DRIVERS OF THE BUSINESS Indian Agrochemical Market The agrochemicals market in India is expected to register 8% CAGR to reach US$ 3.7 billion by FY22 and US$ 4.7 billion by FY25. With the government propagating the development of the agricultural sector and with the recent proposals und

  38. Slide 38: Research & Development

    RESEARCH & DEVELOPMENT R&D labs at Shadnagar and Srikakulam are DSIR recognized. Quality Process Control labs in the development of above locations and active ingredients Ethakota are NABL and intermediates accredited. State-of-the-art Development of R&D lab is GLP R&D manned by New generation, Cert

  39. Slide 39: Production Capacity

    PRODUCTION CAPACITY PRODUCTION CAPACITY 12,000 KL Liquid Formulation 5,600 MT Powder Formulation 35,475 MT Granule Formulation Ethakota Unit, AP Technical Grade 10,000 MT* Srikakulam Unit, AP * Under significant expansion 38

  40. Slide 40: Capacity Expansion Plans

    CAPACITY EXPANSION PLANS NACL is in process of NACL Industries increasing the existing Plant BROWNFIELD Limited, Srikakulam, capacity of 10,000 PROJECT Andhra Pradesh MT/Annum to 25,000 MT/Annum. GREENFIELD PROJECTS NACL Multichem Pvt. Ltd, NACL Spec-Chem Limited, Ranasthalam Mandal, CAPACITY Dahej,

  41. Slide 41: Development at Dahej Greenfield Project

    DEVELOPMENT AT DAHEJ GREENFIELD PROJECT 40

  42. Slide 42: Sustainability – Environment, Health & Safety

    SUSTAINABILITY – ENVIRONMENT, HEALTH & SAFETY Manufacturing State-of-the-art Efficient Plants equipped Strong EHS Plants are certified Zero Liquid equipment for with systems, Integrated Discharge (ZLD) reduced energy occupational processes, Management plants at consumption. health facilities, inspec

  43. Slide 43: Shareholders' Information

    —7~ of AREHOLDERS’ INFORMATION

  44. Slide 44: Shareholders Information

    SHAREHOLDERS INFORMATION Stock Information (as on 28th January 2022) (As on 31st December 2021) Market Capitalization (₹) 1,887.89 Cr Shareholding Pattern (%) Shares Outstanding 19.78 Cr Free Float 377.58 Cr 33.99% Symbol (BSE) / (NSE) 524709 / NACLIND Stock Performance Chart (as on 28th January 202

  45. Slide 45: Thank You

    NACL Industries Limited S-ancial Technologies Pvt. Ltd. (Investor Relations) Plot No 12-A, C Block, Lakshmi Towers, 215, Shivshakti Industrial Estate, J. R. Boricha Marg, Nagarjuna Hills, Punjagutta, Hyderabad - 500082, Lower Parel (E), Mumbai - 400 011 Telangana, India +91 976 906 0608 +91-40 -2440

NACL Industries — Q3 FY2022 Earnings Presentation on 6ix